JHS Svendgaard Retail Ventures reported a significant turnaround in profitability for the first quarter of FY27, posting a standalone net profit of ₹24.06 lakh for the quarter ended June 30, 2026. This marks a sharp improvement from a net loss of ₹3.64 lakh in the corresponding quarter of FY26 and a loss of ₹5.74 lakh in the immediately preceding quarter (Q4FY26).

Revenue from operations rose to ₹401.73 lakh in Q1FY27, compared to ₹327.67 lakh in Q1FY25. However, revenue declined slightly quarter-on-quarter from ₹429.79 lakh in Q4FY26. The company’s total income was driven largely by other income, which stood at ₹166.88 lakh, constituting nearly 29% of total income.

Financial Performance

The following table outlines the key standalone financial metrics for the quarter:

On a consolidated basis, the group reported a net profit of ₹13.46 lakh for Q1FY27, compared to a net loss of ₹7.34 lakh in Q1FY26. Consolidated revenue from operations remained stable at ₹401.73 lakh, identical to the standalone figure.

What the Numbers Show

A notable divergence exists between operating performance and bottom-line results. While the company recorded a slim operating profit before tax of ₹1.61 lakh on a standalone basis, the final net profit of ₹24.06 lakh was significantly boosted by a tax benefit of ₹22.45 lakh (deferred tax income). This indicates that the profitability for the quarter was heavily influenced by tax adjustments rather than core operational margins, which remained thin with total expenses at ₹567.01 lakh against total income of ₹568.61 lakh.

Board Approvals and Rectifications

During its meeting on August 13, 2026, the Board of Directors approved several key matters beyond the financial results:

• Financial Rectifications: The board approved rectifications in the consolidated financial results for the quarter and half-year ended September 30, 2025, as well as the quarter and year ended March 31, 2026. These revisions were made to eliminate certain inter-company balances and transactions that were inadvertently not eliminated during earlier consolidation processes. The changes do not impact standalone financials.
• Director Appointments: Mrs. Richa Sood and Mr. Mukul Pathak were appointed as Additional Non-Executive Independent Directors for a term of five years, subject to shareholder approval.
• Investment: The board approved the subscription of 50 lakh Optionally Convertible Debentures (OCDs) at ₹10 each, carrying a 7% interest rate, issued by Purple Rock Infra Private Limited. This strategic investment aims to strengthen long-term business relations in the infrastructure sector.

The statutory auditors, PSMG & Associates, issued limited review reports on the unaudited standalone and consolidated financial results, confirming no material misstatements were identified.

JHS Svendgaard Retail Ventures Limited has accepted the resignation of Dr. Deepali Bhardwaj as an Independent Director on its Board, effective August 12, 2026. The company disclosed that Dr. Bhardwaj stepped down due to pre-occupancy with other commitments, a common reason for independent director exits in listed entities. Her departure reduces the number of independent directors on the Board until a replacement is appointed, potentially impacting quorum requirements for future board meetings depending on the total board size.

The resignation was formalized through a letter dated August 12, 2026, in which Dr. Bhardwaj confirmed there were no other material reasons for her exit beyond pre-occupancy. She affirmed that she had discharged her duties in accordance with the Companies Act, 2013, and the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, during her tenure. The company’s Company Secretary and Compliance Officer, Kuldeep Jangir, signed the intimation to the stock exchanges.

Regulatory Disclosures

The company filed the necessary disclosures pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, read with Schedule III. Additionally, the filing complied with SEBI Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026. The intimation was submitted to both the Bombay Stock Exchange Limited and the National Stock Exchange of India Limited.

Director Profile and Cessation Details

Dr. Deepali Bhardwaj, holding DIN 06591514, ceased to be a director at the close of business hours on Wednesday, August 12, 2026. In addition to her role at JHS Svendgaard, Dr. Bhardwaj is a Consultant Dermatologist and holds fellowships with ISD (Iran), EADV (Germany), IADVL, and ACSI. She is also associated with Skin & Hair Clinic and serves as Visiting Adjunct Faculty at AIIMS Rishikesh.

Board Composition Impact

The loss of an independent director requires the company to appoint a successor to maintain compliance with SEBI listing regulations, which mandate a minimum proportion of independent directors on the Board. Until a new appointment is made, the Board must ensure that it continues to meet all statutory quorum and composition requirements for valid decision-making. The company has not yet announced a timeline for filling the vacancy.